Adicet Bio, Inc. Deferred Tax Liabilities, Other Comprehensive Income
Adicet Bio, Inc. (ACET) had Deferred Tax Liabilities, Other Comprehensive Income of $13.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesOtherComprehensiveIncome · last filed 2020-03-12
- 2019-12-31: Deferred Tax Liabilities, Other Comprehensive Income $13.00K.
- 2018-12-31: Deferred Tax Liabilities, Other Comprehensive Income $11.00K.
| Period end | Deferred Tax Liabilities, Other Comprehensive Income |
|---|---|
| 2019-12-31 | $13.00K 10-K · filed 2020-03-12 |
| 2018-12-31 | $11.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |